Specifically, we assessed the chromatin accessibility of primary CD138+ plasma cells from two relapsed myeloma patients following treatment with bortezomib, and confirmed a significant enhancement in the intensity of the ATAC‐seq signal at the transcription start site (TSS) regions of the SEI1 gene (Figure 4F). This evidence concerns the gene SERTAD1 and plasma cell myeloma.